Another interesting project conducted by the Institute for Myorcardial Infarction Research can now begin: CAN-SHOCK has received a positive opinion from the ethics committee. The aim of the CAN-SHOCK registry study is to investigate the use of Cangrelor in patients with acute myocardial infarction and PCI after CPR, cardiogenic shock or mechanical or non-invasive ventilation in Germany. With the help of the collected data, evidence on the efficacy and safety of Cangrelor in these high-risk patients will be established. This is a solely retrospective study of patient data collected from medical files. The aim is to collect data from approximately 450 patients in 10-20 clinical trial sites in Germany over a period of 4-6 months.
First patient included in the CRUZ-SENIOR STUDY.Read more
Another important milestone has been achieved, allowing the Institute for Myocardial Infarction Research to generate new data to understand the efficacy and safety of cangrelor in high-risk patients.Read more
Day-to-day research results on the COVID-19 situation in hospitals, based on our own COVID-19 registry.Read more